Ultra-rapid (3 min) test for the SARS-CoV-2 S1 protein
Precise, rapid, early and mass-screening of SARS-CoV-2 incidence in the global general population constitutes one of the few critical solutions to the control of this 21st century pandemic.
Worldwide, expert developers of in vitro diagnostic methods have promptly addressed this challenge by developing novel assay principles and complete tests, whereas exemplary cases of private-public collaborations have paved the way for commercialization and wide distribution of test kits, reagents and assorted devices.
The research team of the Laboratory of Cell Technology at the Agricultural University of Athens is profoundly engaged in the proof-of-concept development of an ultra-rapid (3 min) test for the SARS-CoV-2 S1 protein based on measuring the bioelectric responses of cells bearing target-specific antibodies on their surface, a principle known as Molecular Identification by Membrane.
